During the past decade, The Ottawa Hospital conducted 388 clinical trials. In the 10-year time frame, 388 clinical trials started and 111 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 142 clinical trials started and 50 clinical trials were completed. i.e. 35.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Ottawa Hospital" #1 sponsor was "Ottawa Hospital Research Institute" with 253 trials, followed by "Sunnybrook Health Sciences Centre" with 22 trials sponsored, "McMaster University" with 21 trials sponsored, "Celgene" with 15 trials sponsored and "Hoffmann-La Roche" with 15 trials sponsored. Other sponsors include 426 different institutions and companies that sponsored additional 231 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Ottawa Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 93 trials as a collaborator, "The Ottawa Hospital" with 37 trials as a collaborator, "University of Ottawa" with 17 trials as a collaborator, "Hamilton Health Sciences Corporation" with 14 trials as a collaborator and "The Ottawa Hospital Academic Medical Association" with 14 trials as a collaborator. Other collaborators include 706 different institutions and companies that were collaborators in the rest 419 trials.

According to Clinical.Site data, the most researched conditions in "The Ottawa Hospital" are "HIV Infections" (24 trials), "Breast Cancer" (18 trials), "Venous Thromboembolism" (16 trials), "Osteoarthritis" (13 trials) and "Stroke" (13 trials). Many other conditions were trialed in "The Ottawa Hospital" in a lesser frequency.

Most popular intervention types in "The Ottawa Hospital" are "Drug" (350 trials), "Other" (136 trials), "Procedure" (84 trials), "Device" (68 trials) and "Biological" (54 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (71 trials), "placebo" (9 trials), "Normal Saline" (7 trials), "Rituximab" (7 trials) and "Cyclophosphamide" (6 trials). Other intervention names were less common.

The vast majority of trials in "The Ottawa Hospital" are 692 trials for "All" genders, 48 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are 232 active trials in "The Ottawa Hospital". 9 are not yet recruiting, 140 are recruiting, 79 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 413 completed trials in The Ottawa Hospital, 1 suspended trials, and 48 terminated clinical trials to date.

Out of the total trials that were conducted in The Ottawa Hospital, 40 "Phase 1" clinical trials were conducted, 134 "Phase 2" clinical trials and 231 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 41 trials, and there were also 210 trials that are defined as “Not Applicable".

The Ottawa Hospital has several departments that took part in Clinical trials: "University of Ottawa Eye Institute" - 19 trials, "The Ottawa Hospital Rehabilitation Centre" - 7 trials, "The Ottawa Hospital Cancer Centre" - 310 trials, "Ottawa Hospital and Cancer Center-General Campus" - 45 trials, "The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis" - 4 trials, "Parkinson's and Neurodegenerative Disorders Clinic" - 3 trials, "Irving Greenberg Family Cancer Centre" - 3 trials, "The Ottawa Hospital; Division of Infectious Diseases" - 3 trials, "Regional Centre for the Treatment of Eating Disorders" - 2 trials, "The Ottawa Hospital - Riverside Campus; Gastrointestinal Clinical Research Unit" - 2 trials, "The Ottawa Hospital Woman's Breast Health Centre" - 2 trials